RVLP - Earnings call transcript Q1 2022

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Good morning everyone. My name is Bertney and I will be your conference operator. At this time I like to welcome everyone to the RVL Pharmaceuticals First Quarter 2022 Financial Results Call. All lines have been placed on mute prevent any background noise. After the speakers’ remarks, there will be a question-and-answer period. Instructions] [Operator

Lisa Wilson

on Welcome update release first of Mike Wilson, This Markison; call. for With morning, operator. results XXXX March Investor Chief release RVL RVL’s call RVL. for commercial results financial months are accessed DePetris. Schaub; and This Investors me Chief the Operational to Officer, ended you, Officer, press and through webcast rvlpharma.com. quarter Pharmaceuticals, Officer, section RVL financial the Relations XXXX. XX, and Chief JD can be Thank Executive call Interim press Brian of Financial today's is This detailing this website company issued a three the a Lisa at the

these Securities of and disclaims Exchange statements may uncertainties, intent involve risks the noted statements, Such any specifically those forward-looking those as the forward-looking remind today's projection, events, made statements everyone Commission. differ that Litigation forward-looking get update statements by release future except or may we RVL's regarding are or future to Before projected guarantees any Act. performance performance. the today, from and Actual conference These Private filings belief, are as RVL considered expectation, that be upon materially to on with including not press available express forecast, forward-looking a our information anticipation, the required company's based obligation future intent forward-looking started, I by and the like statements. Reform of in and defined and results call law. statements management as to Securities in would

financial EBITDA. During this non-GAAP measures as such adjusted we call, refer may to

please this rvlpharma.com. from tables to or will loss website, see the of be of webcast for release. The of net adjusted end on call EBITDA year RVL’s continuing For press a today’s the available one reconciliation archived at income operations,

the on filings. webcast, and call the For the was replay to who Brian SEC archived to recorded reference the over CEO, may RVL's And have Thursday, please XXXX. press made recent turn RVL discussed, Since most that Markison. of I’ll with to listening then May related or so this may those topics to benefit call and company's releases XX held be announcements

Brian Markison

and our to great start joining call. behind thank you quarter morning the Good first for off a We're with us.

in on week, new We depth from over open Laure, report we last our recent in proof adds future. the we and the X,XXX of to NewBeauty to likes from to plan a quarter continue People awards with and second Vogue, few. a evidence El, the accounts of grow award the generate utilization drive our we line name mentions received end social to and have The and/or that mounting joins or cadence to Through activated recently from reorder with continuing accounts plan Shape of plan. to accounts opened Magazine

we ahead, to educational team all guidance have and increase plan small sales previously the insight and group a look we presence beginning of increase As we the within expand at QX, service our aesthetics, sales in customer discussed. the expense aesthetic

provide continue the of safety the efficacy are continue aesthetics care we levers drive As growth UPNEEQ we and to clear the and most to eye patient markets, build importantly, satisfaction. and confident are and that us

mind Now it's few in important to keep things. a

competition no a eye share by market in create as category. we care and market aesthetics, defined are a in not and First, we have

widespread see own rapid with of have, and category. safety And our utilization and will attractive patients combined and an blepharoptosis. are who have We those eyelids for margin the droopy profile efficacy or second, UPNEEQ

January joining role in Mike interim capacity, team following in departure. who in DePetris, the our to Now to Andy's CFO mid-April assume turn I'd to like consulting call a over happened the

and speed role the into up depth. to QX financial cover Mike? we'll Now just month in a shy has our Mike some results coming been

Mike DePetris

XXXX increased also XX-Q you, quarterly million year-over-year $XX.X increase for Thank to and after million found and filing operations in the our first to quarterly a regard due continuing $XX.X Total that our to primarily press providing by highlights UPNEEQ. quarterly to $X.X of report SEC product Form markets. results morning appropriate. on as to of quarter in that on revenues, we can with unique the info our begin revenues fourth million, good the release. quarters anticipate later to due today reminder period $XX.X to of to I'll references today's the With specific first back commentary and million net A everyone. sales QX of licensing Brian. And by earnings XXXX, with be

in our Japan, China, and announced the more March Santen with relationship milestones a effective we partner, territories and amended XX, approval agreement take license global allowing to Union. buy our for Santen, expanding March, late out As on and European

recognized the Santen With earnings in signing; income upon the the complete license with licensing immediately process licensing RVL QX. now

sales February in cost sequential $X.X that Most gross to till XX% mid-April volume, from receive higher XXXX. Santen in and contingent fourth an UPNEEQ, million Net sales product note product $X.X commercialization markets The of million intellectual license higher reflecting Take UPNEEQ XXXX entirely due margins of property relating $X.X abnormally UPNEEQ. million more the XX% basis, XXXX were $X.X which in driven XXXX, to by to attributable into of small to commercial general watered million million increase XXXX to are recognize Santen to commentary are increased a approximately importantly, QX the profit for wait this and the to by up force; QX $X.X fees the to the the had $X.X to to unique UPNEEQ. compared Osmolex XXXX. margins $X.X for the would expenses of influenced in The QX high in first increased period Research at the revenue fees. $X.X project the XXXX XXXX payments the period. unique in On as licensing sales a Total excluding milestone sales All a increased our we $X.X period and to on eye Although XX%, first market. reported by profit to million mostly $X.X and, the million primarily current sales the expanded sold million quarter period, We of each to closed personnel increase UPNEEQ, transactional QX which decreased costs to increased XX% medical legal increased of of reflects million. was million $X.X expand income, licensing for $X.X the training relatively million sales, to as go of transaction agreement, forward. primarily unique relate down cash. $X.X margins million. $XX.X in The million for $X.X approximately base. during for increase and from quarter royalties rights compensation of was operating UPNEEQ; XXXX our XX% in only were to sale believe compared care or good million effective aesthetics The and percentage higher represents when higher from be administrative costs by in of rate Santen gain expanded volume lower due under because of sales our and quarter million expenses professional costs $X.X for to margin for we gross we million. there opportunities spending $X.X other believe January and ER, for of and UPNEEQ partly lower a on SG&A offset reflects million that the more by time. we Selling, arbaclofen normalized to the expenses Rounding decrease period. and income on out million primarily lower by being development $X.X million marketing $X.X by and higher percentage

million by non-operating activities largely substantially operating in asset. net and in of and to financial achieved. future million contingent the only QX note any business are expense, revenues, dollars earned when Moving of in million QX of for million and milestone there Such of which amortization of gains of our the value $X.X expenses expense offset below warrants, fair if that other $X to Alora debt income, commitment income. change these represent XXXX were they'll $X relating from however millions be milestones XXXX $X.X sale such legacy losses in contingent from remaining, potential ever in reflecting Alora our contributed sale our Total of is following gains not milestone the tens recognized Pharmaceuticals. related Take non-operating the

value each mark-to-market require determinations re-measure our debt loan term period. October newly or a to result on each Importantly, noted that are the at issued both warrants instruments these fair our us in of recent accounting adjustments XXXX elections reporting and

Forms a interest these expense XX-K measurements. will consisting result, XXXX represented prior non-operating in be of debt. additional activities the By total comparability net and and QX influenced CR determinations a and amortization solely small $X.X to for results XX-Q of expense about million other information by As and contrast comparatively our our were related these accounting of re-measurements.

operations first prior of in a $X.X net million million to net $XX.X Our loss loss compared of for from year the the quarter. continuing quarter was XXXX

of the a Our to the quarter. $XX.X prior of adjusted in EBITDA XXXX loss year $XX.X quarter was million first for compared loss million

now to and turning Finally sheet liquidity. our balance

cash of held we million. equivalent XXXX XX, March of As and cash $XX.X

of obligations $XX.X at debt. had including end financing and debt due million, total $XX million quarter long-term amounts aggregate principle of Our

collected although March the was earlier, as ultimately cash in mentioned licensing our $XX.X revenues the balance of from we XXst Santen As cash, Santen ending QX, recognized excludes receivable April. in million

the UPNEEQ Ethereum incremental of October of focused liquidity to the a as I'd and us $XX commercial become remains upon which our in Importantly, that for to call act additional turn and our ability within UPNEEQ. can is may We product with a important between an prudently JD? to allows balance thereby We commercial necessary. cash. subject satisfy up and draw the minimum rapid With timely Note net satisfaction investing striking to ourselves for draw and highly Agreement conditions, this near-term avail for target invest to our sales under like ambitions commercial managing some through conditions our Accordingly notes to XXXX. of stable over Purchase remain JD fully and borrowing cash it million on growth our certain it we believe include color.

JD Schaub

morning, good everyone. and Thanks Mike,

the wrapping up we're about updates first you the begin side aesthetic front before excited some quarter. momentum very a As out from coming care the growth and on on of eye with heard up strong I'll continued Brian, business.

Our we've throughout accounts within reordering of XX/XX, care the dispense tied of launch. to of seen past through time first weeks XXX pharmacy been our prescriber have time ending every Still paid a seeing a eye year week base this our growth metrics first plus XXX what week continuation lead in excess all our highs as of direct and our of program. growing reaching to

in written that we QX over wise driving brand a with launch on since territory, smaller physicians practices depth described prescription. focus manner With call, our building have of and that from each a quarter-to-quarter. we broad foundation remains a group eye As care our within XX,XXX awareness in step having built in

We physician. the This have providers with overall aligns functional an our resonates to ptosis, impact health. of and with providers growing ocular vision eye around care their a as care ultimately seen goals appreciation relates from eye message really it and as

to the the up been front, tremendous. Brian has mentioned now launch, Turning as aesthetic receptivity

of busy the over a from new evolved We which accounts a this active on be and the strong growing group social There team providers an spilled impact the believe product channel pace growing in are in incredible awareness leading of has into a to weeks the required with carrying integrate given thrilled practices. reordering time The has at acquisition and with indicator technology been also accounts, has through and of growing consumer job which of the media. these potential balancing stickiness result customer new education opportunity. interest awareness the has done to this a continues is how new these into just XX are

territories. from team Importantly, to meetings, just we sales sales expanding launching at layering aesthetic XX beyond educational beginning months: our presence peer-to-peer first presence and XX the in few this our the month growing a about programs are increase person footprint additional to

As the facial seen, protocol. minimally non-invasive building remains market we have establishing move we invasive the what UPNEEQ the routine sells itself. a really of the and forward, part aesthetic product or focus From as

asymmetry At we how objectives learn the new and revolves So this aligns with patient or from aesthetic and finding practices streamlined to that early to around time the aesthetic effort success. practice the practices the with a wants and day, the opportunity tired more as an in look of integral way the perspective. see part many simple thrilled and better the of something than associated with patient to for there The supports outcome of each business do low lids XX,XXX end busy are patient the look also out and needs. lying these a overall sleepy

patients no a UPNEEQ the immediate looking that that pain, Lastly, provide natural treatments call the turn and to looking these are to four majority With like Brian. of that results, like downtime I'd product can satisfaction, no things things: deliver. all for back

Brian Markison

Thanks JD.

our to I it we I'd questions. you. Thank this progress tell think about like could and for the over extremely brand. you prospects Operator, turn are excited to

Operator

Douglas Wainwright. Tsao we [Operator with H.C Instructions] And will question first our take from

Your line open. is

Douglas Tsao

on results. the Hi, Thanks taking good the morning. congrats guys, and great for questions

what from eye actual just Just first, of right sales, care terms now? came percent versus curious I'm aesthetics in

Brian Markison

good the question versus And eye that what of JD from Doug, sales to Hi, want percent came what you one? care? was our morning. spoon aesthetics

JD Schaub

Yes.

Brian Markison

So only. referencing the first quarter

JD Schaub

Yes.

So out coming the we Doug, quarter, what XX/XX. a towards I think about of saw movement was

I both kind growth sides of was pretty a of XX% side here a from even we February in split and terms activations new momentum the forward And we've see receptivity account moved But through think than to think obviously So that drive the there's of as the two into continuing quite the greater moving aesthetic quarter of are of business. revenue upfront. on bit and businesses. continued second I the it between to in March,

Douglas Tsao

Okay, helpful. great. that's And

but $X.X we assume should total from sort though, still? we at so at your care that the weighted a eye little aggregate XX/XX; it towards of comments JD, if in ended look And million probably bit

JD Schaub

fair. that's Yes,

Brian Markison

Doug, through care move then eye the fairly certainly as And Okay. meaningful? to expect year, we surpass sales we aesthetic

Douglas Tsao

expand proxy a of Rules. of company shareholders there that Brian, mechanics? the the more to being clarify Takeover of sort investors willing you. them Thank Irish some recently to language support the [indiscernible] some that filed, was being just some buy your to sort and And on getting of Okay. just then group without you of allow in provision just about triggering of top or you sort stock sort for Could or

Brian Markison

which bit. try outstanding owns the Thanks question we, increase asking bit, the case shares, the simplify we I'll offered an proxy it to the to other XX% all-cash extend be a little are Takeover since Yes. refer our to all what complicated this to by But Irish an for they the would in is than it then shares company. and our of if because concert admit company. than a a I'll Irish the little group party shareholders X.XX%, in the of to we more more Under Rules, is of obligated were insider

So seems offered unusual. in which an essence buy the making to company a little

vote is shareholder to shareholders. Takeover Irish and agreed here asked vote, for capital an subject just We including the from for it's therefore need of really a to the only provision which protect sign business Panel, to the on proxy, have in additional this I think and we the is raise the we've very it's plan have as intention this it myself at And waive X and the important confidence and Proposal is be important. all the letter vote. Should website all and our viewed a current to see info – Takeover Panel they in of upcoming can the our of speaking us

the question appreciate Doug. So you asking I

Douglas Tsao

very you much. helpful. Okay, great. That's Thank

make company company being entirety without to basically sure, support the to buy forced essentially to think you of will the company? the understands, I the I So to support to this just continue everybody understand, allow

Brian Markison

market to choose And we could Correct. raise that. choose to additional discount capital do at if also should the no with we

Douglas Tsao

Okay, Thank great. you so much.

Brian Markison

Doug. right. Thanks All

Operator

question next Cantor. our Chen take We'll with Louise from

is line open. Your

Louise Chen

Hi, quarter, for congratulations my thanks on all progress and this the here. taking questions

runway? pulls So down to pushes that on you and million your I wanted also cash the you I $XX talked draw think about you, are what this have. ask

one you we add a to on you resources price you that I kind then how over yet? of you you And the product; are from you Thank then inflation your your product think going what years, portfolio? your here? impact of do question couple question price plan impact already elasticity people Do secondly, elasticity right curious get – just have? seeing current know So here, on products And of allocate to, but want last and forward lot curious about how you anticipate as and any you going you. got now, to is next to the do think adjacent of

Brian Markison

mail for we products? JD is do then which to brand. thanks this and right our answer don't history it's one to that bundle build we're, us obviously and head just now Two, with Louise, But Mike, acquisitive. get. tell is I add them please didn't – of of more down its The our questions. all and we plan plan be

we we're now and can think this growth projecting, right focused ourselves business. the until we're building really I So doing demonstrate establish everything on is

are more cash a to plan mostly platform, runway, us by them. of – people definitely we've use us how current entertaining on far with lots accelerate driven than of and we and How come we to boots our And right they of we're had the then it. as open help to lot to many capital now can However, open we ground. if today's ideas are

JD's a remarks on bit. let and in it I'll think expand I him

hard. account is us to not open a For that new all really

evaluating sure needs everybody to the business a the new a injector, sample them clinician new the and JD, time that? the to from to wow administering to how a be same do esthetician, clinic. and do new want everybody they if manager, required But treatment, should to the you complete that if also that office in patients and a on and getting make these they're choose to page I the the accounts and experience will assessing think taking a add run in-service, you modality,

JD Schaub

Yes.

about over prudent think emphasizing Louise way base expense simplest we've of think is to from it I standpoint. been kind the management a infrastructure

G&A And cash the effort we're very obviously now, ground a RVL the of streamlined and as boots that We've in allocating this of everything business while right UPNEEQ. breakeven manner of it opportunity out we're but doing to of kind step and towards to driven as getting we up is stickiness of continue a cognizant coming of to to the view point, business, on and the that's the market stable standpoint. So the from being dedicated as flow the, so and reemergence can we I think side front, we marketing. the signs Brian's a wise great see that sales

Brian Markison

I'm So a question Louise that... forgot I sure

Louise Chen

Inflation?

Brian Markison

with Oh, track inflation. bit a that culture think than Inflation, a on the but aesthetics Ethereum, to record we in only I people meet have proven hit who and needs. bit, it's going interest talent other our our the possibly continues and we little on-boarding feel that rate war will for a us be

we and supply think we think affect I as sure on chain, us a other to doing I I going a than So been making set has don't that. go have great we're continuous lot forward, with job supply pretty Nephron see much there. negatively

think well. would JD little to as a bit I like add

JD Schaub

think environment stickiness. standpoint, about in feel this really product I the good Well a from we

as environment, think of seen drop particularly allows operate, think, years of think the perspective working over you it's historically I against in terms And the from things systems obviously business gives build a growth in for some aesthetic the about it lot irrespective procedures price mean, account resilient be aesthetics. expanded XX a like optimized drive my we're have factors. that it's macroeconomic rate the look and grow. we I that openings we've And aesthetic to and the me seen model side XX, that off and last I we've into backdrop of to of that fill not demand inflation to that and confidence channel us the haven't all think new continues just all, I We as continues of this when go. rising

good the business environment. we So product feel really and in about our type of model this

Louise Chen

Thank very much. Great. you

Brian Markison

Thanks Louis.

Operator

Greg our take Truist Securities. from next We question Fraser with will

Your line is open.

Greg Fraser

consumer the more are Good guys. placed been can questions. speak and multiple then bit building you can aesthetics, a about practices about order On asking to the about talk over about you has awareness, are for reorders? morning patients the more what thinking providers Thanks size consumer you. awareness their for time? how have And you Thank changing extent order that taking And how average UPNEEQ? side

Brian Markison

with orders Greg. So I'll the thanks and the start for question,

around that's This think The of would think I you the expect to seeing So a we of orders I new pretty see size consistently. is orders what couple what we're are a product. cases actually opening and expected.

as well, I and work XX which think and being practice? And terms look a as X.X of the intrigue. interest at you reordering lot in of being is to grow reorder my I in very three to the cases to week-to-week do weeks. consistent cases. closer And we to second continues the reorder see it But maybe tick a through the up then how you there's third closer going accounts, been that's first so think

in good signs practice. this happening to of begins what's product as each really So shape some terms within take

Mike DePetris

I think, the awareness, question. was Consumer next

Brian Markison

are in a eye greater yes, both so absolutely side practices then, the the influx product. the of asking care patients we about seeing and on walking in And aesthetic

between I this whether branding much how with people has things there media, there standpoint of asking. you since base. patient for their because feedback eye. practices area, with is from that, never a a right the their focus consistency also we time the and to they think, these of active now product of the but social No creating open so we're doubt the link not awareness are as been in it's practice, in as that's in more rooms, are in focused a on drop can like we're also whatever the consumer lift that and treatment lid One peers, it's both waiting rooms, on that spending believe will, if I of terms a practices terms contributing. in And resulting that these a is

sort here and of that's now. So

we we be ramping getting on think before reasonable As a to foundation direct-to-consumer we spend. about to a laying start it, continue focused look of practices number at aesthetic to and

And the we'll so a the that focus content what that looking put maybe testing we be setting, some that messaging, sort certain behind pilot and terms efforts to in do more in have different making the is we've above interim in of marketing at and markets, engagement sure continue to seen far consumer continues so the minimal of average.

of we look at that's it. So in kind summary, how

Greg Fraser

taking the questions. Thanks for

Operator

with We'll Tsao take H.C question Douglas follow-up a Wainwright. from

is line Your open.

Douglas Tsao

good Thanks the taking for Hi, follow-up. morning.

I people? of quarter. in the salesforce to you question you're that I'm think it seeing a third earlier? why indicated to now; do XQ the right just aesthetics curious given Brian expected finding Is you not the expand you. Thank momentum just sort just understand that of why

Brian Markison

right. I think we're really the game, new thoroughly in

what went right Our the would we single XX-person from to kind looking we eye from were expand, but every we made space, to person expect within in experience our the I team. market always for coming as team a ramp. time that in the really also company. did when think the expense we've playbook we're resources the we build resource few for And also of expand to down into had shift had seeing new so a care pretty right good we it live our And the a plan pull aesthetic in And February.

to I think want JD; you to that. add probably

JD Schaub

Yes.

of I when driver it's an I think, how page certainly territories with really the same doing it. and be months. to the expansion; we off we're recent look doing added we're But we at in we've look, about, think talked on of one kind have and what

a be that's of between just managers get the want so couple the guns of ownership so will they put we then we ground that part that we sort in the going We're regions, we in, new are so to XX% expansion with integral need put, the consistent to QX to blazing. the guess, today teams runway aesthetic of take through territories. footprint hiring couple And meeting want I building. And process when that training growth current a over to the it's hit add an adding and managers an more of than them and a

in being XX So additional thoughtful reps layer as couple XX regions. and we of of impact about in a an group just considerate little to bit a of

Brian Markison

And making sure that within we that the given. we expense previous guidance room have the have

Douglas Tsao

And it should the of review how you. year? Brian, and could the about go of think you just sort just the expense and rest cadence we through guidance the just Thank

Brian Markison

it, at right Yes, going but plan. to obviously I If rate. month said change looking we're we're mean, will expense right tailwinds, And consistently a some we're per $X we've that add to now roughly to then our not typically be on operating and million see run our that. impressive we pretty

to range analyst the quarter looks of Our very estimates, second strong. within the be is which

and put going So execute. with and OpEx to yes, million staying the month our we're down we're a $X head

Douglas Tsao

Okay, great. Thank you.

Brian Markison

Okay.

Operator

Cantor. a from we And with Louise will follow-up Chen take

Your line is open.

Louise Chen

I just curious, was when additional, for you anticipated taking your going revenues, part you're these here. question XX to thought reps your that plan, to Thanks. add, I year? and could XX about guidance and think gave that or you drive upside guidance my to thanks of is on Hi, said follow-up the so this that that you first for quarter everything

Brian Markison

Completely the Louise. part plan, of

Louise Chen

you. Thank Okay.

Operator

with Barclays. Instructions] our Prasad next take from Balaji [Operator question We'll

open. Your line is

Balaji Prasad

the And questions. thanks for Hi, everyone. morning, good

the last minutes missed So, of the Brian, I ten call.

apologies any So questions. I'm of repeating if the

see towards spend. to launches, versus terms your promotional be and several when in but peers your indirectly the Firstly, of campaigns. your tens dollars in you're seem dollars of spends hundreds even probably sense or of efforts I spend, their what can millions of a I I'm complimenting you, of with get similar tens, spending

the there that you So what that in magazines, sense across is I seeing with where. magazines, it have can being if on if impact And I creates? the the bookkeeping $X recall Is I'm for too results. if and be featured reported don't million a contingent milestone aesthetics ocular around in extension the immediate quantify want and is the seem are maybe I spending see early gains, effect the this thought Thanks. aesthetic still side be in that ties I of March any we seeing on you, for numbers the beauty industry, trend and there and fillers. end that quantifying want something question seen to way I that something of $X.X on Second, you get you that from the XQ. of is of know you're at strong to million Lastly, in neurotoxins to there? or it? a pretty but day is it's how missing?

Brian Markison

with to we're then to our answer, that? want take All, cash way you Mike, going work start backward. the

Mike DePetris

milestone Yes, recognized anything not you'll Balaji were find within contingent we that we recognized that payments the That's revenues. operating income those that below income.

$X that is contingent cash So million classified quarter below to operations. the in gain

et they But So if med going not more like spas, tailwinds affecting a see remember, in it filler, you it sufficient means are we look to at class of we're because et are to kind a cetera. the toxin cetera. love industry people the anchored

of for see the So grows more seeing enthusiasm Vogue, and we're the UPNEEQ. we're growth Shape category from, mentioned is help forgot happening had from and people we the go going is Magazine and to aesthetic the market housewives out she show or I proof us. one more general our other particular brand which what's or own And on was there. going And only is about to are it El as day. social the and the Instagram talking seeing the you we're

And of extremely ground So the see into a pharmacy and the it proof asked we're and who organic, fill we rate have see. that gratifying it's building for when patients prescription, swell. come to a is seeing social lot high is

On up the we peers. But effort competition. our no are than look, lot we're medical our fact the ramp aesthetics. expense certainly marketing. of of the education a spend bit lot directed to space, less a a of field of followed digital. that we now a we're lot But support is sales look, also have conscious by in the And field spend our beginning And is marketing majority toward spending

build migraine a the we're So toxin to it. or seeing we're rewarded can And carefully. we're spend a and not we for are going race we being carefully, growth in race

JD, want think, you to I to add do that?

JD Schaub

you No, up. it I think summed

Mike DePetris

All right.

one the if nailed me all out, know. I think, questions, I Balaji, left but let So I

Balaji Prasad

got all. you Thank you all. No, it

Mike DePetris

right. Thank you, sir. All

Operator

questions We Markison for I Brian closing on this have no further additional the time. turn any remarks. back the or at to program line over will

Brian Markison

are listening to operator, putting listen everyone for because are the a and the doing you. thank job thank and with they later, want of us. RVL you. thank if Okay again hell a Thank also or joining really And at team appreciate for they up I call it. I

Operator

This for does program. you your Thank participation. conclude today's

And a day. time. any wonderful at have disconnect may You

RVL Pharmaceuticals (RVLPQ) 12 May 222022 Q1 Earnings call transcript